BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cozar JM, Robles-Fernandez I, Rodriguez-Martinez A, Puche-Sanz I, Vazquez-Alonso F, Lorente JA, Martinez-Gonzalez LJ, Alvarez-Cubero MJ. The role of miRNAs as biomarkers in prostate cancer. Mutat Res Rev Mutat Res 2019;781:165-74. [PMID: 31416574 DOI: 10.1016/j.mrrev.2019.05.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Guan Y, Teng J, Jia Z, Zhang G, Ai X. CircTRRAP (hsa_circ_0081234) participates in prostate cancer progression and glycolysis by HOXA1 via functioning as a miR-515-5p sponge. Appl Biol Chem 2022;65. [DOI: 10.1186/s13765-022-00722-w] [Reference Citation Analysis]
2 Bilal M, Javaid A, Amjad F, Youssif TA, Afzal S. An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs. Transl Oncol 2022;26:101542. [PMID: 36148731 DOI: 10.1016/j.tranon.2022.101542] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Hekımler Öztürk K, Mutlu İçduygu F, Özgöz A, Özorak A. miR-221, miR-650 and miR-4534 as diagnostic markers in prostate cancer and their relationship with lymphatic invasion. Turkish Journal of Biochemistry 2022;47:435-443. [DOI: 10.1515/tjb-2021-0154] [Reference Citation Analysis]
4 Zhang L, Parvin R, Fan Q, Ye F. Emerging digital PCR technology in precision medicine. Biosensors and Bioelectronics 2022;211:114344. [DOI: 10.1016/j.bios.2022.114344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Bernardes JGB, Fernandes MR, Rodrigues JCG, Vinagre LWMS, Pastana LF, Dobbin EAF, Medeiros JAG, Dias Junior LB, Bernardes GM, Bernardes IMM, Santos NPCD, Demachki S, Burbano RMR. Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate. Genes 2022;13:622. [DOI: 10.3390/genes13040622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xu C, Wang Z, Zhang L, Feng Y, Lv J, Wu Z, Yang R, Wu T, Li J, Zhou R, Tian Z, Bai J, Zhang H, Lan Y, Lv Z. Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-021-02441-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Prasad D, Prabhavathi V, Santosh Sushma P, Sai Babu M, Aruna P, Khan IA. Role of Circulating MicroRNAs in Prognosis and Diagnosis of Cancers. Role of MicroRNAs in Cancers 2022. [DOI: 10.1007/978-981-16-9186-7_7] [Reference Citation Analysis]
8 Shi T, Morishita A, Kobara H, Masaki T. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:10630. [PMID: 34638971 DOI: 10.3390/ijms221910630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Beveridge DJ, Richardson KL, Epis MR, Brown RAM, Stuart LM, Woo AJ, Leedman PJ. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. Sci Rep 2021;11:18003. [PMID: 34504167 DOI: 10.1038/s41598-021-97190-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Shi T, Morishita A, Kobara H, Masaki T. The Role of microRNAs in Cholangiocarcinoma. Int J Mol Sci 2021;22:7627. [PMID: 34299246 DOI: 10.3390/ijms22147627] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Xue J, Chen K, Hu H, Gopinath SCB. Progress in gene therapy treatments for prostate cancer. Biotechnol Appl Biochem 2021. [PMID: 33988271 DOI: 10.1002/bab.2193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fu C, Zhang Q, Wang A, Yang S, Jiang Y, Bai L, Wei Q. EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis. Mol Oncol 2021;15:1543-65. [PMID: 33605506 DOI: 10.1002/1878-0261.12930] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
13 Altschuler J, Stockert JA, Kyprianou N. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance. Int J Mol Sci 2021;22:2100. [PMID: 33672595 DOI: 10.3390/ijms22042100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 He Z, Shen F, Qi P, Zhai Z, Wang Z. miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin. Cell Death Discov 2021;7:18. [PMID: 33462201 DOI: 10.1038/s41420-020-00387-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
15 Ai Y, Tang Z, Zou C, Wei H, Wu S, Huang D. circ_SEPT9, a newly identified circular RNA, promotes oral squamous cell carcinoma progression through miR-1225/PKN2 axis. J Cell Mol Med 2020;24:13266-77. [PMID: 33090705 DOI: 10.1111/jcmm.15943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
16 Akoto T, Bhagirath D, Saini S. MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer. Cancer Drug Resist 2020;3:804-18. [PMID: 33426506 DOI: 10.20517/cdr.2020.30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Tamaru S, Kajihara T, Mizuno Y, Mizuno Y, Tochigi H, Ishihara O. Endometrial microRNAs and their aberrant expression patterns. Med Mol Morphol 2020;53:131-40. [PMID: 32350620 DOI: 10.1007/s00795-020-00252-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Dirks RC, Burney HN, Anjanappa M, Sandusky GE, Hao Y, Liu Y, Schmidt MC, Nakshatri H. Breast Heterogeneity: Obstacles to Developing Universal Biomarkers of Breast Cancer Initiation and Progression. J Am Coll Surg 2020;231:85-96. [PMID: 32311464 DOI: 10.1016/j.jamcollsurg.2020.03.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zenner ML, Baumann B, Nonn L. Oncogenic and tumor-suppressive microRNAs in prostate cancer. Curr Opin Endocr Metab Res 2020;10:50-9. [PMID: 33043165 DOI: 10.1016/j.coemr.2020.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Konoshenko MY, Lekchnov EA, Bryzgunova OE, Zaporozhchenko IA, Yarmoschuk SV, Pashkovskaya OA, Pak SV, Laktionov PP. The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms. Diagnostics (Basel) 2020;10:E38. [PMID: 31936850 DOI: 10.3390/diagnostics10010038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
21 Phan LMT, Gul AR, Le TN, Kim MW, Kailasa SK, Oh KT, Park TJ. One-pot synthesis of carbon dots with intrinsic folic acid for synergistic imaging-guided photothermal therapy of prostate cancer cells. Biomater Sci 2019;7:5187-96. [PMID: 31588457 DOI: 10.1039/c9bm01228a] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
22 Hrach HC, Mangone M. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy. Int J Mol Sci 2019;20:E4638. [PMID: 31546754 DOI: 10.3390/ijms20184638] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]